Figure 4From: Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study Proportion of patients achieving a response at month 6 as defined by the EULAR. EULAR, European League Against Rheumatism.Back to article page